Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent Diabetes

Published:2014 Issue:10 Volume:78 Page:2512-2515
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Ogawa Hisao¹²,Matsui Kunihiko³,Saito Yoshihiko⁴,Sugiyama Seigo⁵,Jinnouchi Hideaki⁵,Sugawara Masahiro⁶,Masuda Izuru⁷,Mori Hisao⁸,Waki Masako⁹,Yoshiyama Minoru¹⁰,Watada Hirotaka¹¹

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

2. Deputy Director General of the Hospital, National Cerebral and Cardiovascular Center

3. Department of Community Medicine, Kumamoto University Hospital

4. First Department of Internal Medicine, Nara Medical University

5. Jinnouchi Hospital

6. Sugawara Clinic

7. Medical Examination Center, Takeda Hospital

8. Yokohama Sotetsu Bldg, Clinic of Internal Medicine

9. Department of Internal Medicine, Shizuoka City Hospital

10. Department of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City University

11. Department of Metabolism and Endocrinology, Graduate School of Medicine, Juntendo University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/10/78_CJ-14-0810/_pdf

Reference15 articles.

1. Reverse Vessel Remodeling But Not Coronary Plaque Regression Could Predict Future Cardiovascular Events in ACS Patients With Intensive Statin Therapy

2. Intensity of Statin Therapy, Achieved Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Japanese Patients After Coronary Revascularization

3. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

4. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

5. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial;Diabetes & Metabolism Journal;2024-07-31

2. Association of statins with nonalcoholic fatty liver disease in patients with diabetes;Journal of Investigative Medicine;2024-05-15

3. Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins;The American Journal of Cardiology;2023-09

4. Risk of diabetes with statins;BMJ;2023-05-12

5. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study;Yonsei Medical Journal;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3